Call Our Free Legal Helpline Anytime

or call

20 June 2015

Xarelto Lawsuits – MDL Cases Progress in US Federal Court

The dozens of Xarelto lawsuits are moving forward in the U.S. Federal Court in the Eastern District of Louisiana, as several important pre-trial deadlines are fast approaching for the multi-district litigation (MDL) proceedings.

Hundreds of Xarelto lawsuits have been filed by patients who’ve suffered Xarelto complications and life-threatening Xarelto side effects, along with family members who’ve lost a loved one due to fatal complications from the blood thinner drug Rivaroxaban.

The recent court proceedings have included witness depositions, the creation and distribution of plaintiff and defendant fact sheets, and matters related to the selection of which cases will be used as bellwether cases —- that is, cases which are used to test the general viability of the Xarelto lawsuits that have been clustered as part of the MDL.

Upcoming Dates in Xarelto Lawsuit Cases

The following are a few significant dates in the Xarelto MDL proceedings:

  • Thursday, June 11, 2015 is “science day”. The proceedings will include informative scientific presentations about the blood thinner medication, the conditions that it’s used to treat and the complications.
  • Monday, June 15, 2015 is the date set for a discovery session for as many as 60 plaintiffs who have been identified as possible candidates for the bellwether trials for the Xarelto MDL cases.
  • On June 15, it’s expected that the court will also set dates for selecting which cases will serve as bellwether trials. It’s expected that the dates for the start of the Xarelto bellwether trials will be announced shortly thereafter.

The court has also set a few rolling deadlines. Defendants must provide info on all Xarelto lawsuits that are currently underway in state courts five days prior to each status conference in order to allow for better coordination between federal and state authorities.

Fact sheets about each plaintiff must also be provided to the court within 60 days of filing a new Xarelto lawsuit.

Background on the Xarelto Lawsuits

Manufactured by Janssen Pharmaceuticals — a division of Johnson & Johnson — Xarelto is a blood thinner drug (also known as an anti-coagulant medication) which has been available to patients since 2011.

Xarelto indications include conditions like deep vein thrombosis (DVT), non-valvular atrial fibrillation, a stroke risk, pulmonary embolism and a tendency to form blood clots, particularly after operations such as knee replacements and hip replacements. Many initially preferred this blood thinner drug over warfarin, also sold as coumadin, because of the simplified Xarelto dosing. Xarelto dosing is simplified by the fact that it does not require the intensive monitoring and dosage adjustment that’s necessary for coumadin.

But when comparing Xarelto vs. coumadin, it’s vital to note that there is no Xarelto antidote, while vitamin K can be used as a coumadin reversal agent. Even the competing “new generation” blood thinner Pradaxa can be eliminated from the patient’s system via dialysis in the event of an uncontrolled bleeding incident. But Xarelto reversal is impossible; the patient must wait for the drug levels to naturally decrease. In a healthy, young person between ages 20 and 45, the Xarelto half life is between 5 to 9 hours — a timeframe that can seem like a lifetime in the event of a major bleeding event.

In the Xarelto lawsuits, many claim it was simply irresponsible to release a blood thinner drug without an antidote or reversal agent. Others argue that vital information — such as the risk of side effects and the lack of an antidote or Xarelto reversal agent — was downplayed in marketing materials, Xarelto commercials and even in the literature distributed to patients and physicians.

Xarelto side effects can be many and varied, including intestinal bleeding, kidney bleeding, abdominal bleeding, rectal bleeding, bleeding on the brain and blood clots, among many other ailments. These are just a few in a long list of some very serious Xarelto side effects.

Attorneys Representing Clients in Xarelto Lawsuits

The attorneys with Meldofsky Law Firm are currently amongst the law firms that are accepting new cases from clients who’ve suffered complications from Xarelto. Bleeding and serious side effects have led to sky high medical bills, emotional distress, health complications, and even death in a number of cases. But compensation can now be sought in the form of a lawsuit, although the law limits how much time you have to file a claim.

Were you, a family member or a loved one prescribed this drug? Have you suffered complications from Xarelto? Serious side effects or even death of a loved one from bleeding or other complications may qualify you for compensation so please contact The Meldofsky Law Firm for a complementary and confidential no obligation consultation. Just call 877-274-8672.

You may be eligible for financial compensation.

Name is required.
Email is required.
Phone is required.
Medical condition required.